EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudieOpen Access · CC BY-NC 4.0

Clinical Features and Outcomes of Glutamic Acid Decarboxylase‐65 Antibody‐Associated Pure Cerebellar Ataxia and Stiff Person Syndrome Spectrum Disorders: A Single‐Center Cohort Study

Jonathan D Krett iD, Yujie Wang, Ashley Miles, Herbert R Chen, Hanyeh Afshar, Aisha Elfasi, Doris D Lin, Scott D Newsome

European Journal of Neurology · 2025-05 · 32 (5)

DOI: 10.1111/ene.70166 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Journal of Neurology, online erschienen am 08.05.2025. Verfasst von Jonathan D Krett und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Stiff-Person Syndrome, Glutamate Decarboxylase, Cerebellar Ataxia, Autoantibodies. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Not applicable.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cerebellar ataxia is associated with greater disability in glutamic acid decarboxylase‐65 (GAD65) antibody‐associated neurological disorders and can occur in isolation or as part of stiff person syndrome (SPS) spectrum disorders (SPSD). We sought to phenotypically characterize this subpopulation with cerebellar dysfunction.

Methods

Observational study of GAD65 antibody‐seropositive individuals with cerebellar involvement seen at Johns Hopkins (1997–2024). Subjects were divided into two groups based on cerebellar dysfunction in the presence (SPSD; SPS‐plus and progressive encephalomyelitis with rigidity and myoclonus [PERM]) or absence (pure cerebellar ataxia [pCA]) of classic SPS features. Clinical and paraclinical findings were analyzed descriptively.

Results

Seventy‐two patients were selected among 356 (62 SPSD, 10 pCA). Mean age for patients with pCA was 58 ± 16 years versus 46 ± 15 years for SPSD ( p = 0.012). Males comprised 50% of the pCA group versus 19% SPSD ( p = 0.049). High GAD65 antibody serum titers occurred in 76% without group differences, while cerebrospinal fluid antibody positivity occurred in 35/37 (95%) of SPSD versus 5/8 (62%) pCA ( p = 0.033). Although the modified Rankin scale was similar (median 3, interquartile range 2–4) in both groups, the brief ataxia rating scale indicated a higher burden of cerebellar abnormalities in pCA versus SPSD, and there was a trend toward greater cerebellar atrophy by MRI in pCA ( p = 0.44). Rituximab and benzodiazepine use was more frequent in SPSD versus pCA.

Conclusions

GAD65 antibody‐associated ataxia is disabling irrespective of accompanying SPS features. Patients with pCA were older, more commonly male, and may have more frequent cerebellar atrophy than those with SPSD. Prospective validation of cerebellar outcomes and neuroimaging findings is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stiff-Person SyndromeGlutamate DecarboxylaseCerebellar AtaxiaAutoantibodiesHumansMaleFemaleMiddle AgedAdultAgedCohort Studies

Stichwörter der Autor:innen

GAD‐65autoimmune neurologycerebellar ataxianeuroimmunologystiff person syndrome

Substanzen

Glutamate DecarboxylaseAutoantibodiesglutamate decarboxylase 2

Autor:innen und Institutionen

  • Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Neurology, University of Washington Medical Center - Northwest, Seattle, Washington, USA.
  • Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Jonathan D Krett

Förderung

  • Not applicable

Zitieren

APA

Krett, J. D., Wang, Y., Miles, A., Chen, H. R., Afshar, H., Elfasi, A., Lin, D. D., & Newsome, S. D. (2025). Clinical Features and Outcomes of Glutamic Acid Decarboxylase‐65 Antibody‐Associated Pure Cerebellar Ataxia and Stiff Person Syndrome Spectrum Disorders: A Single‐Center Cohort Study. European Journal of Neurology, 32(5). https://doi.org/10.1111/ene.70166

Vancouver

Krett JD, Wang Y, Miles A, Chen HR, Afshar H, Elfasi A, et al. Clinical Features and Outcomes of Glutamic Acid Decarboxylase‐65 Antibody‐Associated Pure Cerebellar Ataxia and Stiff Person Syndrome Spectrum Disorders: A Single‐Center Cohort Study. European Journal of Neurology. 2025;32(5). doi:10.1111/ene.70166

BibTeX
@article{Krett2025,
  author = {Krett, Jonathan D and Wang, Yujie and Miles, Ashley and Chen, Herbert R and Afshar, Hanyeh and Elfasi, Aisha and Lin, Doris D and Newsome, Scott D},
  title = {Clinical Features and Outcomes of Glutamic Acid Decarboxylase‐65 Antibody‐Associated Pure Cerebellar Ataxia and Stiff Person Syndrome Spectrum Disorders: A Single‐Center Cohort Study},
  journal = {European Journal of Neurology},
  year = {2025},
  volume = {32},
  number = {5},
  doi = {10.1111/ene.70166}
}
Kostenlos starten →